Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Total article views   Abstract views HTML views PDF downloads Totals
10,638 Dovepress* 5,149 1,997+ 1,043 7,146
PubMed Central* 0 3,492 698 3,492
Totals 5,149 5,489 1,741 10,638
*Since 14 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 1 0 0 4 9

View citations on PubMed Central and Google Scholar